ProCE Banner Activity

TANGO: Switch to DTG/3TC Maintains Virologic Suppression at Wk 48 Across Patient Demographics and Baseline Third Agent Classes

Slideset Download
Conference Coverage
Switching from a TAF-based regimen to DTG/3TC maintains virologic suppression across patient subgroups regardless of patient demographics, disease characteristics, or baseline third agent.

Released: November 08, 2019

Begin Activity

Share

Provided by

Provided by the USF Health
ProCE Banner

Supporters

Supported by educational grants from

Gilead

Janssen Therapeutics Division of Janssen Products

ViiV Healthcare